Bachem Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BANB.SW research report →
Price Chart
About the company
Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds.
- CEO
- Anne-Kathrin Stoller
- IPO
- 1998
- Employees
- 2,725
- HQ
- Bubendorf, BL, CH
Get TickerSpark's AI analysis on BANB.SW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.80B
- P/E
- 38.89
- Fwd P/E
- 32.78
- PEG
- 3.48
- P/S
- 8.19
- P/B
- 4.02
- EV/EBITDA
- 31.42
- Div Yield
- 1.16%
- Gross Margin
- 27.00%
- Op Margin
- 19.41%
- Net Margin
- 21.02%
- ROE
- 10.27%
- ROIC
- 6.43%
Latest fiscal year · YoY change
- Revenue
- $695.07M+14.8%
- Gross Profit
- $199.73M+9.4%
- Op Income
- $150.28M
- Net Income
- $148.79M+23.7%
- EPS
- $1.98+23.7%
- OCF Growth
- +85.5%
- FCF Growth
- +65.1%
- 52W High
- $83.25
- 52W Low
- $48.52
- 50D MA
- $73.20
- 200D MA
- $66.24
- Beta
- 0.80
- RSI (14)
- 61
- Avg Volume
- 132.66K
No earnings-call transcripts are available for BANB.SW yet.
- Free Float
- 41.4%
- Shares Outstanding
- 74.94M
- Float Shares
- 30.99M
Held by 281 ETFs
Biggest fund positions in BANB.SW by dollar value.
Our BANB.SW coverage
Recent articles, reports, and earnings notes.
No research on BANB.SW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BANB.SW report →Bachem Confirms Growth and Expects a Strong Second Half 2026
feeds.newsfilecorp.com · Jul 30
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
feeds.newsfilecorp.com · Jul 21
Bachem Annual General Meeting 2026
feeds.newsfilecorp.com · Apr 29
Bachem Reports Strong Sales Growth and Sustained High Profitability
feeds.newsfilecorp.com · Mar 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.